Stereotaxis, Inc. (STXS) stock
STXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/3018% below fair value
$0.88+0.08 (+9.89%)
Close on Nov 17, 2026Market cap $88.39MP/E –Yield –
Stereotaxis cash
Cash and short-term investments held at the end of each period.
Stereotaxis's cash was $10.49M at Jun 30, 2026. For fiscal 2025 it was $13.42M, up 9.9% from the year before. Over ten years it grew 9.1% a year on average. The highest annual figure on record is $43.94M in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.42M | +9.9% |
| FY2024 | Dec 31, 2024 | $12.22M | -38.4% |
| FY2023 | Dec 31, 2023 | $19.82M | -33.3% |
| FY2022 | Dec 31, 2022 | $29.70M | -26.0% |
| FY2021 | Dec 31, 2021 | $40.14M | -8.6% |
| FY2020 | Dec 31, 2020 | $43.94M | +45.6% |
| FY2019 | Dec 31, 2019 | $30.18M | +179.6% |
| FY2018 | Dec 31, 2018 | $10.80M | +192.9% |
| FY2017 | Dec 31, 2017 | $3.69M | -56.6% |
| FY2016 | Dec 31, 2016 | $8.50M | +52.0% |
| FY2015 | Dec 31, 2015 | $5.59M | -23.1% |
| FY2014 | Dec 31, 2014 | $7.27M | -47.2% |
| FY2013 | Dec 31, 2013 | $13.78M | +77.1% |
| FY2012 | Dec 31, 2012 | $7.78M | -44.3% |
| FY2011 | Dec 31, 2011 | $13.95M | -60.4% |
| FY2010 | Dec 31, 2010 | $35.25M | +15.4% |
| FY2009 | Dec 31, 2009 | $30.55M | +0.6% |
| FY2008 | Dec 31, 2008 | $30.36M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $10.49M | +50.6% |
| Q1 FY2026 | Mar 31, 2026 | $14.62M | +37.9% |
| Q4 FY2025 | Dec 31, 2025 | $13.42M | +9.9% |
| Q3 FY2025 | Sep 30, 2025 | $10.51M | -1.5% |
| Q2 FY2025 | Jun 30, 2025 | $6.97M | -52.6% |
| Q1 FY2025 | Mar 31, 2025 | $10.60M | -39.9% |
| Q4 FY2024 | Dec 31, 2024 | $12.22M | -38.4% |
| Q3 FY2024 | Sep 30, 2024 | $10.66M | -51.8% |
| Q2 FY2024 | Jun 30, 2024 | $14.68M | -35.8% |
| Q1 FY2024 | Mar 31, 2024 | $17.63M | -31.3% |
| Q4 FY2023 | Dec 31, 2023 | $19.82M | -33.3% |
| Q3 FY2023 | Sep 30, 2023 | $22.10M | -28.6% |
| Q2 FY2023 | Jun 30, 2023 | $22.88M | -31.7% |
| Q1 FY2023 | Mar 31, 2023 | $25.66M | -26.9% |
| Q4 FY2022 | Dec 31, 2022 | $29.70M | -26.0% |
| Q3 FY2022 | Sep 30, 2022 | $30.94M | -23.1% |
| Q2 FY2022 | Jun 30, 2022 | $33.50M | -20.3% |
| Q1 FY2022 | Mar 31, 2022 | $35.10M | -17.3% |
| Q4 FY2021 | Dec 31, 2021 | $40.14M | -8.6% |
| Q3 FY2021 | Sep 30, 2021 | $40.24M | -7.7% |
| Q2 FY2021 | Jun 30, 2021 | $42.05M | -4.4% |
| Q1 FY2021 | Mar 31, 2021 | $42.45M | +51.5% |
| Q4 FY2020 | Dec 31, 2020 | $43.94M | +45.6% |
| Q3 FY2020 | Sep 30, 2020 | $43.60M | +37.7% |
| Q2 FY2020 | Jun 30, 2020 | $44.01M | +419.4% |
| Q1 FY2020 | Mar 31, 2020 | $28.02M | +210.0% |
| Q4 FY2019 | Dec 31, 2019 | $30.18M | +179.6% |
| Q3 FY2019 | Sep 30, 2019 | $31.65M | +173.5% |
| Q2 FY2019 | Jun 30, 2019 | $8.47M | -29.4% |
| Q1 FY2019 | Mar 31, 2019 | $9.04M | -22.2% |
| Q4 FY2018 | Dec 31, 2018 | $10.80M | +192.9% |
| Q3 FY2018 | Sep 30, 2018 | $11.57M | +157.9% |
| Q2 FY2018 | Jun 30, 2018 | $11.99M | +138.1% |
| Q1 FY2018 | Mar 31, 2018 | $11.61M | +102.4% |
| Q4 FY2017 | Dec 31, 2017 | $3.69M | -56.6% |
| Q3 FY2017 | Sep 30, 2017 | $4.49M | -51.5% |
| Q2 FY2017 | Jun 30, 2017 | $5.04M | – |
| Q1 FY2017 | Mar 31, 2017 | $5.74M | – |
| Q4 FY2016 | Dec 31, 2016 | $8.50M | – |
| Q3 FY2016 | Sep 30, 2016 | $9.24M | – |
See a number that looks wrong?